LONDON, November 10, 2014 /PRNewswire/ --
As a sister journal of Journal of Plastic, Reconstructive and Aesthetic Surgery, JPRAS Open is similarly dedicated to publishing case reports, short communications, and full-length research papers on topics relating to plastic, reconstructive and aesthetic surgery. It seeks to broaden understanding and perspective on these topics including among others, improve surgical care by providing highlights in general reconstructive surgery. cleft lip, palate and craniofacial surgery; head and neck surgery; skin cancer; breast surgery; hand surgery; lower limb trauma; burns; and aesthetic surgery.
Editor-in-Chief, Stefan Hofer, University of Toronto, said of the launch, "There is always a need to continually improve surgical care by highlighting peer-reviewed, cutting-edge research. JPRAS Open will quickly peer review and publish the most current source of information and references in our specialty. As an open access journal, papers will be available to all, without a subscription."
Andrew Berin, Publishing Director of Elsevier's Surgery journals added, "We are thrilled to expand our publishing relationship with the British Association of Plastic, Reconstructive and Aesthetic Surgeons by publishing JPRAS Open. With its launch we hope to offer clinicians and medical researchers an exciting new open access platform to showcase their work in the field of plastic and reconstructive surgery."
For more information or to submit an article, go JPRAS Open: http://www.jprasopen.com
About Open Access Publishing at Elsevier
Elsevier has been providing open access publishing options since 2005. Today, researchers can choose to publish open access in over 1,600 established peer-reviewed journals over 100 open access journals and these numbers will continue to grow rapidly. All of Elsevier's open access publications have been peer reviewed, ensuring that the broader community not only reads the latest research but that it is factual, original and of the highest quality and ethical standards. For more information about Elsevier's open access program, visit http://www.elsevier.com/openaccess
Elsevier is the world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions - among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey - and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world-leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).